HM
AGIO icon

HealthCor Management’s Agios Pharmaceuticals AGIO Stock Holding History

HealthCor Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,532,960
Closed -$79.2M – 75
2021
Q1 		$79.2M Buy
1,532,960
+535,890
+54% +$26.5M 2.8% 11
2020
Q4 		$43.2M Buy
+997,070
New +$39.4M 1.67% 24
2020
Q2 		– Sell
-408,844
Closed -$14.5M – 51
2020
Q1 		$14.5M Sell
408,844
-288,546
-41% -$13.3M 0.62% 38
2019
Q4 		$33.3M Buy
+697,390
New +$26.4M 1.19% 35

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management's AGIO Position: Q2 2021 in Review

HealthCor Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2021, closing a stake of 1,532,960 shares — an estimated $79.2M sold.

HealthCor Management first reported a position in AGIO in Q4 2019 and held it in 4 quarters. The position peaked at $79.2M in Q1 2021. 185 funds tracked by Wall St. Rank hold AGIO as of Q2 2021.

  • HealthCor Management reported no remaining Agios Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • HealthCor Management sold 1,532,960 Agios Pharmaceuticals shares in Q2 2021, an estimated $79.2M.
  • HealthCor Management first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • HealthCor Management's Agios Pharmaceuticals position peaked at $79.2M in Q1 2021.
  • 185 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2021.

Based on HealthCor Management's 13F filing for Q2 2021, filed 16 Aug 2021.